Dermal fibroblast neoplasm with a minor epidermal component, with a variety of clinical forms. Often locally aggressive with a high propensity for recurrence after surgical excision, but does not metastasize.
Incompletely characterized, complex, and multifactorial:
However, viral involvement unconfirmed:
Genetic susceptibility to sarcoids suspected, and a polygenic inheritance pattern proposed:
Most common neoplasm of horses, with a prevalence of 112% reported, and accounting for 1565% of all neoplasms, ahead of SCC, melanoma, and papilloma.
Single or multiple lesions in a variety of body regions; may occur at sites of previous injury. May progress into more aggressive forms spontaneously.
Likely caused by a complex association between BPV and inheritable traits of the horse, with environmental influences.
Wide variety of clinical presentations lends to numerous differentials. Accurate diagnosis cannot be based on clinical appearance alone (1 study of 345 cases determined 31% error in presumed diagnosis of sarcoid).
High propensity for recurrence after treatment, and for development of new tumors at new sites. Greatest success in treatment is achieved by close monitoring and prompt additional treatment as required. Observation without treatment is an option for small tumors; however, potential for aggressive growth remains.
A variety of medical treatments are described with varying success rates. Medical options may be best considered supplementary to surgical excision/debulking, but may have value as sole treatments for small superficial lesions.
Monitoring closely for recurrence is the prime need, with prompt additional treatment indicated if recurrence occurs.
Fly control/avoidance, good patient hygiene, and good management hygiene practices are anecdotally reported to reduce the incidence of transmission between horses.
Related to surgical excision (wound breakdown, restricted movement, wound infections). Interference with performance and cost of treatments may result in requests for euthanasia.
Author: Linda J. Vogelnest
Consulting Editor: Gwendolen Lorch
Acknowledgment: The author and editor acknowledge the prior contribution of Sandra Nogueira Koch.
Click here for Additional Further Reading